China Traditional Medicine

Archive for January, 2011

According to the South of the punctuation information proprietary data, our cardiovascular medicine from 2007 to 2009 were 23.4 billion market size, 280 billion yuan, 34.8 billion, its compound growth rate of 21.94%, higher than the cardiovascular overall drug market and drug markets throughout the hospital compound annual growth rate, increase in policy support, the aging trend of increasing raw material prices and other favorable factors, the cardiovascular medicine will be more future market broad

It is the fourth of 2008, “National Health Service” The survey data show: from 1993 to 2008, 15 years, our population the prevalence of cardiovascular disease showed a rapid growth trend, the average annual growth rate of 8.37%. By the total population of 1.33 billion in 2008 estimated that the diagnosis by a doctor of cardiovascular disease, the number of cases from the 0.37 million in 1993 increased to 114 million people in 2008. Visible, with the accelerated aging process, cardiovascular and cerebrovascular diseases have become of the main problems of the health of residents.

Cardiovascular drugs on a global scale is the first category of drug, accounting for 20% of the total size of drugs; in China, although the cardiovascular drugs are the second largest category of drugs, but over the country 20% of total drug sales .

At present, China cardiovascular pharmaceutical drugs in China, second only to anti-infectives market, ranked No. 2 in 2007, the market scale reached 700 billion in 2008 to 81.3 billion yuan in 2009, rose to 98.3 billion yuan, the overall development of the market is very mature. The market size of nearly 3 years the average annual compound growth rate of 18.55%, market growth and better.

Three years of continuous expansion of market size

According to SFDA Southern Medicine Economic Institute Co., Ltd., Guangzhou Pharmaceutical punctuation information (hereinafter referred to as the south of the punctuation information) proprietary data, our cardiovascular medicine 2007 to 2009 the market size was 23.4 billion yuan, 280 billion 34.8 billion, the average annual compound growth rate of 21.94%, higher than the overall cardiovascular drug market and drug markets throughout the hospital compound annual growth rate.

The growth rate from the point of view, cardiovascular drug market continues to expand over the past 3 years, from 2007 to 2009 chemical medicine and Chinese medicine are growing size of the market trend, and the growth rate increased every year.

And cardiovascular medicine medication was significantly higher than the growth rate of the overall size of the hospital medicine and cardiovascular drug market growth overall.

Market concentration is low

According to the South of the sample hospitals in nine cities punctuation information database data show that from 2007 to 2009, cardiovascular disease drug market concentration of brand watch, the top four purchases total (CR4) were the market share of 12.36%, 14.56% and 17.14%, the first eight brands combined (CR8) market share were 21.40%, 23.96% and 27.10%, according to the market determine the value of the concentration index CR8: 20% ? CR8 <40%, may determine the cardiovascular and cerebrovascular China disease drug medicine market is a low concentration of market concentration competitive, more intense competition in the market

New health care reform on the impact of the retail pharmacy makes it urgent to seek new growth and diversification as its inevitable path. However, as the pharmaceutical industry’s retail outlets, drug properties of its existence has been the most important features, thus, return to health of Chinese medicine and its derivative products of the high profit margins and brand effect, a diversified retail business under the new high ground.

In the July 14, organized by the Hong Mei medicine, “the golden age of development of Chinese medicine pharmacy opportunity Summit” on more than 100 from around the country in charge of pharmaceutical retail chain enterprises who discussed the situation of the new pharmacy health care reform business ideas.

Entrepreneurs that the participants in the new primary care medical reform reconfigure resources situation, the return to the Chinese medicine pharmacy management and dissemination will be to cope with stress, one of the best ways to seek development.

Primary health care sector resources in the retail market segmentation

“The implementation of new health care reform impact on pharmacy will make a thorough re-distribution of primary health care resources, the rise of the concept of health management will be entrusted with the survival of pharmacy and continue to rise in the main battlefield.” At the forum, deputy general manager Li from Yunnan Hong medicine Select the case said.

This reporter has learned, the new health reform policy implementation, especially implementation of the system of essential drugs and raise the level of primary health care, etc. for improving primary health care environment a series of policies and measures, for purposes of retail pharmacies all have some negative. Under the new direction of health reform implementation, full implementation of 2011 basic drug system, the progressive introduction of community-based drug directory zero slip, primary health care institutions will be part of the original drugs plus government financial subsidies and other cost-sharing. Although the implementation of the current situation around, the basic drugs needed to zero the difference is not financial investment is far from guaranteed, but the determination from the state perspective, this does not affect the pace of the gradual implementation of zero slip.

“The first consultation through the community, two-way referral and insurance reimbursement, based drugs zero difference, and one to one’s health management, community health will eventually become a minor illness, chronic disease and common gathering place for the largest passenger flow, while the top three hospital outpatient flows will be reduced to the current 30%, pharmacies will face a sharp drop in passenger traffic situation. “OTC Pharmaceutical Division, Hong Mei Li Hanhui the case, told reporters, general manager, community health agencies to the residents to control the unprecedented strengthening of residents before the completion of health management home.

Another reporter was also informed that, in addition to policy implementation at the national level the impact on pharmacies, the local doctor in order to better solve your problem, have the layout of the primary health care resources more sink. For example, Beijing has close to 3,000 community health services, 3,500 pharmacies, the ratio is almost 1:1, community health care institutions take root in communities all to complete the 3 km, 15 minutes healthy circle layout.

Innovative business ideas of Chinese medicine

“In the new medical reform and the impact of supporting policies, the development of retail pharmacies want to survive, you need to find a new growth point, while the pharmaceutical business and its transmission is one of the directions are worth considering, which is traditional Chinese medicine new growth enterprises. “Hong Mei Li Hanhui medicine, general manager of OTC Division, told reporters the case.

In fact, the observation of traditional Chinese medicine market development can be found, as a Chinese tradition for thousands of years of culture and arts, Chinese medicine along with rapid economic development has not fully play its role. But in Western medicine, “quick, clear the mechanism” and so the concept was gradually eroded under the impact or even replaced. Although in recent years, countries have come to realize the seriousness of the problem, and gradually introduced the relevant documents and measures to encourage the development of Chinese medicine, but in the private and OTC markets, the development of Chinese medicine has not been a big improvement, the number of Ten years ago, Chinese medicine pharmacy medicine cabinet, was gradually filled with health care products, cosmetics, glass-fronted cabinets replaced daily.

“Development of Chinese medicine in recent years by a number of factors, including the Chinese market, business philosophy and regulatory levels of restrictions. “Lihan Hui said.

Li Hanhui analysis, the current Chinese Herbal Medicine in the pharmacy business is difficult to reason, and mainly affected by several aspects: the lack of brand appeal of product management; medicine purchase of raw materials quality is not high; pharmacies within the category of lack of medicine, not be able to meet customer demand; lack of Chinese medicine practitioners and pharmacists of the team, and Chinese medicine services are generally weak; lack of marketing and so on. Therefore Li Hanhui that should suit the remedy to address the problem through a series of reforms, including re-orientation of Chinese Herbal Pieces from the past emphasis on medical treatment only for the treatment and gradually elevated to health as one of the strategic development of height, while the conditions in the policy allows increase Zuotang medicine, the famous old Chinese Zuotang employed to enhance Chinese culture and drug culture, services and contacts. Chinese medicine services while actively training personnel, the formation of traditional Chinese-style mentoring mentoring, this traditional Chinese medicine to improve the service to enhance health knowledge dissemination, and provides a series of health products, medical services chain pharmacies in the community hospital with an important competitive differentiation weapons. In addition, the specific terms of management, and national influential Chinese business cooperation, the establishment of Chinese medicine health clinics and ginseng plate, the rapid formation of new profit growth point.; increase Chinese Herbal Medicine in the Medicare reimbursement, chain pharmacies and related community hospitals cooperation and jointly developing Chinese Herbal Medicine of the market; At the same time, pharmacies have to enhance Chinese Herbal Medicine of the activity of display and enhance consumer visual experience.

Four Guan Mu Tang Wen mei (prescription Mongolian name: Brissenden -4 soup)

Prescription: Bunge wood 5g, hair myrobalan (or Toosendan) 3g, Terminalia chebula, Phyllanthus emblica (or gardenia) of the 1g.

Method: 4 or more taste, crushed into coarse powder, sift, and mix.

Function: heat, dry “yellow water.” Used to heat the “yellow water” disease, edema, all kinds of arthritis, damp skin disease.

Dosage: Adult first 3-59, day 1-2 times a decoction, or a decoction to wash the skin lesion.

Sammi Piper longum pills (prescription Mongolian name: that if -3)

Recipe: Terminalia 10g, Kusnezoffii 5g, Piper longum 3g.

Method: more than 3 taste, crushed into fine powder, sift, mix, pan-cold water pill, vermilion coating, polishing, and dry.

Function: eliminate “stick”, with the exception of “yellow water” …… the body’s temperature, the heat of the tissues and organs and spirit are all excited, “Sheila” in the play. “Sheila” Piansheng, will place a variety of warm diseases, such as mouth pain, spit acid, and looked so manic performance. “Bada dry” refers to the body of a mucus-like substance, the characteristics of a cold. “Bada dry” dysfunctional, in addition to the performance of the general signs of cold, but also easily lead to stagnation of water solution increased secretion of the emergence of various phenomena.